SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Pack Allan I)
 

Search: WFRF:(Pack Allan I) > (2020-2024) > Positive airway pre...

Positive airway pressure treatment affects respiratory symptoms and gastro-oesophageal reflux : the Icelandic Sleep Apnea Cohort Study

Emilsson, Össur Ingi (author)
Uppsala universitet,Lung- allergi- och sömnforskning,Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
Aspelund, Thor (author)
Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.
Janson, Christer (author)
Uppsala universitet,Lung- allergi- och sömnforskning
show more...
Benediktsdottir, Bryndis (author)
Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
Juliusson, Sigurdur (author)
Landspitali Natl Univ Hosp Iceland, Dept Otolaryngol, Reykjavik, Iceland.;Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
Maislin, Greg (author)
Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
Pack, Allan I. (author)
Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
Keenan, Brendan T. (author)
Univ Penn, Div Sleep Med, Dept Med, Philadelphia, PA 19104 USA.
Gislason, Thorarinn (author)
Landspitali Natl Univ Hosp Iceland, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.
show less...
 (creator_code:org_t)
European Respiratory Society, 2023
2023
English.
In: ERJ Open Research. - : European Respiratory Society. - 2312-0541. ; 9:5
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aim: To study the effect of positive airway pressure (PAP) treatment on nocturnal gastro-oesophageal reflux (nGOR) and respiratory symptoms among clinical obstructive sleep apnoea (OSA) patients.Methods: 822 patients newly diagnosed with OSA referred for PAP treatment were recruited. 732 patients had a 2-year follow-up visit with continuous PAP compliance data (366 full PAP users, 366 partial/non-PAP users). They answered questionnaires, including reporting of nGOR, sleep and respiratory symptoms and general health. Patients with nGOR symptoms once a week or more were defined as "with nGOR". Those without nGOR symptoms and nGOR medication were defined as "no nGOR". Others were defined as "possible nGOR".Results: At 2-year follow-up, PAP treatment among full users resulted in decreased nGOR (adjusted OR 0.58, 95% CI 0.40-0.86) and wheezing (adjusted OR 0.56, 95% CI 0.35-0.88) compared with partial/non-PAP users. Decreased nGOR, among both full and partial/non-users of PAP treatment, was associated with a decrease in productive morning cough (adjusted OR 4.70, 95% CI 2.22-9.99) and a decrease in chronic bronchitis (adjusted OR 3.86, 95% CI 1.74-8.58), but not decreased wheezing (adjusted OR 0.90, 95% CI 0.39-2.08). A mediation analysis found that PAP treatment directly led to a decrease in wheezing, not mediated through nGOR. Conversely, PAP treatment decreased productive cough mediated through a decrease in nGOR.Conclusion: In an unselected group of OSA patients, PAP treatment for 2 years was associated with a decrease in nGOR and respiratory symptoms. The PAP treatment itself was associated with less wheezing. A decrease in nGOR through PAP treatment was associated with a decrease in productive cough.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view